Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 25 11 2020
accepted: 04 06 2021
entrez: 9 8 2021
pubmed: 10 8 2021
medline: 27 10 2021
Statut: epublish

Résumé

Influenza A virus (IAV) has a higher genetic variation, leading to the poor efficiency of traditional vaccine and antiviral strategies targeting viral proteins. Therefore, developing broad-spectrum antiviral treatments is particularly important. Host responses to IAV infection provide a promising approach to identify antiviral factors involved in virus infection as potential molecular drug targets. In this study, in order to better illustrate the molecular mechanism of host responses to IAV and develop broad-spectrum antiviral drugs, we systematically analyzed mRNA expression profiles of host genes in a variety of human cells, including transformed and primary epithelial cells infected with different subtypes of IAV by mining 35 microarray datasets from the GEO database. The transcriptomic results showed that IAV infection resulted in the difference in expression of amounts of host genes in all cell types, especially those genes participating in immune defense and antiviral response. In addition, following the criteria of 

Identifiants

pubmed: 34367124
doi: 10.3389/fimmu.2021.632798
pmc: PMC8337049
doi:

Substances chimiques

Antiviral Agents 0
Basic-Leucine Zipper Transcription Factors 0
Batf2 protein, human 0
HERC5 protein, human 0
Intracellular Signaling Peptides and Proteins 0
Tumor Suppressor Proteins 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

632798

Informations de copyright

Copyright © 2021 Zhou, Dong, Liu and Tang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Virology. 2015 Aug;482:117-27
pubmed: 25863179
Antiviral Res. 2016 Sep;133:23-31
pubmed: 27451344
Cell Immunol. 1998 May 25;186(1):1-7
pubmed: 9637759
Mol Cells. 2018 Apr 30;41(4):271-281
pubmed: 29629559
J Exp Med. 2017 May 1;214(5):1313-1331
pubmed: 28356392
Blood. 2012 Mar 29;119(13):3128-31
pubmed: 22310910
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10666-71
pubmed: 24994901
Mol Cancer. 2020 Jul 10;19(1):114
pubmed: 32650804
PLoS One. 2013 Nov 14;8(11):e78912
pubmed: 24244384
J Virol. 2005 Dec;79(23):14933-44
pubmed: 16282492
Nucleic Acids Res. 2015 Dec 2;43(21):10321-37
pubmed: 26490959
J Virol. 2020 Dec 22;95(2):
pubmed: 33115872
Am J Public Health. 2020 May;110(5):669-676
pubmed: 32267748
J Virol. 2017 Aug 10;91(17):
pubmed: 28637751
J Virol. 2011 Nov;85(21):10955-67
pubmed: 21865398
J Virol. 2006 Aug;80(15):7469-80
pubmed: 16840327
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
J Immunol. 2011 Jan 1;186(1):164-73
pubmed: 21106851
Analyst. 2017 Jan 26;142(3):442-448
pubmed: 28091625
J Immunol. 2010 May 15;184(10):5777-90
pubmed: 20385878
J Virol. 2014 Jan;88(2):1051-64
pubmed: 24198415
J Innate Immun. 2014;6(2):182-91
pubmed: 23867918
Nat Rev Dis Primers. 2018 Jun 28;4(1):3
pubmed: 29955068
Biochim Biophys Acta. 2016 Nov;1859(11):1440-1448
pubmed: 27664935
J Leukoc Biol. 2012 Jul;92(1):11-20
pubmed: 22442495
Viruses. 2017 Dec 07;9(12):
pubmed: 29215570
Cell. 2009 Dec 24;139(7):1255-67
pubmed: 20064372
Infect Dis Clin North Am. 2019 Dec;33(4):907-932
pubmed: 31668198
Sheng Wu Gong Cheng Xue Bao. 2015 Jan;31(1):123-34
pubmed: 26021086
Science. 2015 Apr 24;348(6233):448-53
pubmed: 25814066
Front Immunol. 2018 May 31;9:1193
pubmed: 29904383
J Virol. 2013 Aug;87(15):8363-71
pubmed: 23740986
BMC Bioinformatics. 2013;14 Suppl 6:S1
pubmed: 23734902
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2253-8
pubmed: 20133869
Blood. 2008 Sep 1;112(5):2028-34
pubmed: 18544685
J Immunol. 2016 Mar 1;196(5):2004-9
pubmed: 26826244
Int Immunol. 2019 May 21;31(6):371-383
pubmed: 30753547
Int Immunol. 2018 May 24;30(6):255-265
pubmed: 29534174
BMC Syst Biol. 2011 Nov 11;5:190
pubmed: 22074594
mBio. 2014 Feb 04;5(1):e01102-13
pubmed: 24496798
PLoS One. 2013 Jul 25;8(7):e69374
pubmed: 23935999
J Biol Chem. 2012 Mar 23;287(13):9804-9816
pubmed: 22318733
Respir Res. 2010 Oct 28;11:147
pubmed: 21029402
J Virol. 2008 May;82(10):4908-19
pubmed: 18353940
Nat Microbiol. 2020 Dec;5(12):1490-1503
pubmed: 32839537
PLoS One. 2012;7(3):e33732
pubmed: 22470468
mSphere. 2018 Jan 3;3(1):
pubmed: 29299535
Apoptosis. 2015 Nov;20(11):1457-70
pubmed: 26386572
Am J Respir Cell Mol Biol. 2011 Jun;44(6):906-13
pubmed: 20705938
Virol J. 2019 Oct 29;16(1):124
pubmed: 31665046
Int J Mol Sci. 2017 Nov 01;18(11):
pubmed: 29104227
Am J Respir Cell Mol Biol. 2011 Sep;45(3):582-91
pubmed: 21239608
J Virol. 2014 Dec;88(23):13593-601
pubmed: 25231314
BMC Bioinformatics. 2011 Jan 26;12:35
pubmed: 21269502
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20906-11
pubmed: 19074269

Auteurs

Ao Zhou (A)

College of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan, China.
Basic Medical College, Southwest Medical University, Luzhou, China.

Xia Dong (X)

College of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan, China.

Mengyun Liu (M)

College of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan, China.

Bin Tang (B)

Basic Medical College, Southwest Medical University, Luzhou, China.
Key Lab of Process Analysis and Control of Sichuan Universities, Yibin University, Yibin, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH